These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 6543580)

  • 1. [Treatment and prevention of ABO incompatibility during pregnancy with combined traditional Chinese medicine and western medicine and its effect on fetus and newborn].
    Li ET
    Zhong Xi Yi Jie He Za Zhi; 1984 Mar; 4(3):137-8. PubMed ID: 6234088
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis, prevention, and therapy in hemolytic disease of the newborn.
    Polesky HF
    Clin Lab Med; 1982 Mar; 2(1):107-22. PubMed ID: 6821161
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of maternal-fetal blood group incompatibility with traditional Chinese herbal medicine.
    Bian X; Xu Y; Zhu L; Gao P; Liu X; Liu S; Qian M; Gai M; Yang J; Wu Y
    Chin Med J (Engl); 1998 Jul; 111(7):585-7. PubMed ID: 11245041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Elution technics for the detection of antibodies in hemolytic disease of the newborn].
    Gota F; Dallavalle FM
    Arch Sci Med (Torino); 1980; 137(4):567-9. PubMed ID: 7018457
    [No Abstract]   [Full Text] [Related]  

  • 5. [Laboratory study of traditional Chinese medicine for the prevention and treatment of hemolytic diseases of the newborn infant].
    Qian ML
    Zhonghua Fu Chan Ke Za Zhi; 1984 Oct; 19(4):207-9, 256. PubMed ID: 6543580
    [No Abstract]   [Full Text] [Related]  

  • 6. [Problems of ABO hemolytic disease in the newborn infant].
    Novachev D; Markov L
    Akush Ginekol (Sofiia); 1980; 19(3):253-7. PubMed ID: 6992621
    [No Abstract]   [Full Text] [Related]  

  • 7. ABO haemolytic disease of the newborn: laboratory prediction and post-natal diagnosis.
    Lockyer WJ
    Med Lab Sci; 1982 Jul; 39(3):287-95. PubMed ID: 6752621
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current trends in the prevention and therapy of hemolytic disease in the fetus and newborn infant. Review note].
    Marsico S
    Arch Ostet Ginecol; 1965; 70(6):508-30. PubMed ID: 5327174
    [No Abstract]   [Full Text] [Related]  

  • 9. Laboratory identification of erythroblastosis fetalis.
    Kurtz EM; Pappas AA; Cannon A
    Ann Clin Lab Sci; 1982; 12(5):388-97. PubMed ID: 6814344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of hemolytic disease of the fetus and the newborn: it is necessary to act].
    Mannessier L; Alie-Daram S; Roubinet F; Valat AS; Depoortère MH; Fournié A; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Sep; 29(5):441-4. PubMed ID: 11011272
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis and treatment of the immune hemolytic anemias.
    Rosenfield RE; Diamond SH
    Haematologia (Budap); 1981; 14(3):247-56. PubMed ID: 7035308
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.